Qube Research & Technologies (QRT)
PROK icon

Qube Research & Technologies (QRT)’s ProKidney PROK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-306,764
Closed -$3.05M – 2909
2022
Q2 		$3.05M Buy
+306,764
New +$3.03M 0.02% 653

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PROK Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of ProKidney (PROK) in Q3 2022, closing a stake of 306,764 shares — an estimated $3.05M sold.

Qube Research & Technologies (QRT) first reported a position in PROK in Q2 2022 and held it in 1 quarter. The position peaked at $3.05M in Q2 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 306,764 ProKidney shares in Q3 2022, an estimated $3.05M.
  • Qube Research & Technologies (QRT) first reported a position in ProKidney in Q2 2022 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s ProKidney position peaked at $3.05M in Q2 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.